Start-Upomics Featured RavGen got Natera to cough up $57m. What's going on with non-invasive screening test IP? HOT-TAKE: RavGen got Natera to cough up $57m. What's going on with non-invasive screening test IP?! Brian Krueger 21 Jan 2024 • 4 min read
